A novel chemokine-based signature for prediction of prognosis and therapeutic response in glioma.

CNS neuroscience & therapeutics(2022)

引用 4|浏览6
暂无评分
摘要
In all, our results highlighted a potential 4-chemokine signature for predicting prognosis in glioma and reflected the intricate immune landscape in glioma. It also threw light on integrating tailored risk stratification with precision therapy for glioblastoma.
更多
查看译文
关键词
chemokine,glioma,immunotherapy,prognostic signature,tumor microenvironment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要